Aprea Therapeutics, Inc. Rings the Opening Bell in Celebration of its IPO

Date & Time Oct 4, 2019 9:15am - 9:45am
Location Nasdaq MarketSite, 4 Times Square New York


Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company headquartered in Boston, Massachusetts with research facilities in Stockholm, Sweden, focused on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein, visited the Nasdaq MarketSite in Times Square.

In honor of the occasion, Christian S. Schade, President & CEO, rang the Opening Bell.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now